This systematic review had several limitations: problem of homogeneity of studies; survival data could not be analyzed; few studies focused on the androgen receptor; absence of consideration of hormonal treatments in the analysis of the population; lack of data about the precise tumor localization; and intra-tumoral heterogeneity with potential sampling bias. Here, AR is linked to neoplasm.